The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

The scope of securities litigation has further expanded to include Aquestive Therapeutics (AQST), with a class action lawsuit filed for investors who acquired securities between June 16, 2025, and January 8, 2026. This follows the ongoing legal action against automotive giant Stellantis N.V. (STLA) for alleged violations of federal securities laws and Rule 10b-5. Additionally, the class period for the lawsuit against Power Solutions International (PSIX) has been specifically defined as May 8, 2025, through March 2, 2026. These cases join existing litigation against Vital Farms (VITL) and Babcock & Wilcox, where companies are accused of issuing misleading statements that resulted in investor losses. The accumulation of these legal challenges is expected to weigh on the stock performance of the involved entities as lead plaintiff deadlines approach in 2026. Affected investors are encouraged to evaluate their legal options and monitor the specified class periods.
Sign in to access this content
Sign In